| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K85133207 |
| PharmacoGx | BRD-K85133207 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FLT3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | RUNX1T1 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | GSX1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | PGAM2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | CACFD1 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | GADD45G | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | SLC25A52 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | ENTPD2 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
| mRNA | NPIPA5 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-07 |
| mRNA | SATL1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
